Kathie J. Lenzen
2018
In 2018, Kathie J. Lenzen earned a total compensation of $629.4K as Former Chief Financial Officer at Xtant Medical Holdings.
Compensation breakdown
| Option Awards | $524,784 |
|---|---|
| Salary | $104,615 |
| Total | $629,399 |
Lenzen received $524.8K in option awards, accounting for 83% of the total pay in 2018.
Lenzen also received $104.6K in salary.
Rankings
In 2018, Kathie J. Lenzen's compensation ranked 11,105th out of 14,244 executives tracked by ExecPay. In other words, Lenzen earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,105 out of 14,244 | 22nd |
Division Manufacturing | 4,475 out of 5,758 | 22nd |
Major group Chemicals And Allied Products | 1,695 out of 2,119 | 20th |
Industry group Drugs | 1,436 out of 1,808 | 21st |
Industry Biological Products, Except Diagnostic Substances | 278 out of 339 | 18th |
Source: SEC filing on September 20, 2019.
Lenzen's colleagues
We found three more compensation records of executives who worked with Kathie J. Lenzen at Xtant Medical Holdings in 2018.